Replacement of Cytogenetics by aCGH in Prenatal Diagnosis
Demonstration Trial on Replacement of Cytogenetics by Array Comparative Genomic Hybridisation (aCGH) in Prenatal Diagnosis
Sponsor: The University of Hong Kong
A observational or N/A phase clinical study on Prenatal Diagnosis, this trial is completed. The trial is conducted by The University of Hong Kong and has accumulated 4 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2019 — Jan 2021 [monthly]
Completed
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.